Cargando…
Safety of paclitaxel-coated devices in the femoropopliteal arteries: A systematic review and meta-analysis
BACKGROUND: Clinical benefit of paclitaxel-coated devices for patients with peripheral arterial disease has been confirmed in randomized controlled trials (RCTs). A meta-analysis published in 2018 identified late mortality risk over a long follow-up period due to use of paclitaxel-coated devices in...
Autores principales: | Zhang, Chenyang, Yin, Guosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560511/ https://www.ncbi.nlm.nih.gov/pubmed/36227807 http://dx.doi.org/10.1371/journal.pone.0275888 |
Ejemplares similares
-
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019) -
Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
por: Scheer, F, et al.
Publicado: (2015) -
Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Katsanos, Konstantinos, et al.
Publicado: (2018) -
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials
por: Klumb, Christof, et al.
Publicado: (2019) -
Association of mortality with drug-coated devices in femoropopliteal artery based on the nationwide data
por: Choi, Hyunsook, et al.
Publicado: (2021)